Document Detail


Comprehensive evaluation of Safyral(®) 2012.
MedLine Citation:
PMID:  23181528     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The incidence of pregnancies affected with neural tube defects (NTDs) has been reduced by food fortification programs and public health campaigns promoting folic acid supplementation, but the incidence of NTDs in the USA has not achieved the full potential reduction expected with adequate periconceptional folate utilization. In seeking new ways to access sexually active women at risk for pregnancy, one option would be to link folic acid supplementation to contraceptive use. Since birth control pills are the most popular method of reversible contraception in the USA, it would seem quite logical to find a way to supplement them. To this end, a very efficient folate, levomefolate calcium salt (metafolin), has been added to drospirenone-containing oral contraceptives in equimolar concentrations to the recommended supplements of folic acid to reduce the risk for pregnancy and to reduce the risk of NTDs in pregnancies that occur while women are taking the pill or shortly after they discontinue its use. This article will focus on the need for such folate supplementation and will summarize the contraceptive and noncontraceptive benefits of the 30 µg EE/3 mg drospirenone pill (Yasmin(®), Bayer Healthcare, NJ, USA) to which has been added 451 metafolin (Safyral(®), Bayer Healthcare). The new information about thromboembolism risks associated with use of drospirenone-containing pills is also discussed.
Authors:
Anita L Nelson
Related Documents :
11113278 - Differences between neonates and adults in the urokinase-plasminogen activator (u-pa) p...
16688678 - Myeloperoxidase accumulates at the neutrophil surface and enhances cell metabolism and ...
2375288 - Energy cost of physical activity throughout pregnancy and the first year postpartum in ...
25469928 - Reducing unintended pregnancies: a microsimulation of contraceptive switching, disconti...
10171028 - Effective handling of health-related leaves of absence.
7465868 - Effects of (15s)-15-methyl prostaglandin e2 alpha methyl ester and estrogens upon the c...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Women's health (London, England)     Volume:  8     ISSN:  1745-5065     ISO Abbreviation:  Womens Health (Lond Engl)     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101271249     Medline TA:  Womens Health (Lond Engl)     Country:  England    
Other Details:
Languages:  eng     Pagination:  619-33     Citation Subset:  IM    
Affiliation:
1000 W. Carson Street, Torrance, CA 90509, USA. anitalnelso@earthlink.net.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Letrozole: advancing hormone therapy in breast cancer.
Next Document:  Chemoprevention of breast cancer.